Chemosensitizing with liposomes containing oligonucleotides
CA 2476437 A1 · Owner: Gokhale, Prafulla · Inventors: Ahmad, Imran; Kasid, Usha; Mewani, Rajshree
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to the use of oliognucleotide containing cationic liposomal formulations to enhance the efficacy of chemotherapy and/or radiotherapy, particularly as a means to chemosensitize cancer are tumor tissues to the efficiencies of chemotherapy. This is particularly advantageous in the context of treatment of ras expressing tumors such as breast lung, pancreatic and prostate cancer.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 14, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 14, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 14, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.